Market Capitalization (Millions $) |
35 |
Shares
Outstanding (Millions) |
9 |
Employees |
- |
Revenues (TTM) (Millions $) |
-3 |
Net Income (TTM) (Millions $) |
-8 |
Cash Flow (TTM) (Millions $) |
-3 |
Capital Exp. (TTM) (Millions $) |
0 |
Lexaria Bioscience Corp
Lexaria Bioscience Corp is a biotechnology company based in Canada. The company focuses on the development of drug delivery technology that enhances the performance and effectiveness of pharmaceuticals. Lexaria's patented DehydraTECH platform uses lipid-based carriers to deliver drugs and other bioactive compounds more efficiently into the bloodstream. This technology has shown potential in improving the delivery of various substances, including cannabinoids, nicotine, and nonsteroidal anti-inflammatory drugs. Lexaria is actively involved in partnerships and collaborations with other companies to develop and commercialize products utilizing its technology. The company aims to provide improved delivery solutions that can enhance the effectiveness and consumer experience of various pharmaceuticals and nutraceuticals.
Company Address: #100 ? 740 McCurdy Road Kelowna 0
Company Phone Number: 765.6424 Stock Exchange / Ticker: NASDAQ LEXX
LEXX is expected to report next financial results on April 13, 2024. |
|
|